News | Structural Heart

March 14, 2023 — The Society of Thoracic Surgeons (STS) has developed and launched a new risk calculator to estimate the ...

Home March 14, 2023
Home
News | Drug-Eluting Balloons

March 14, 2023 —MedAlliance has announced enrollment of over 1,000 patients in its ground-breaking SELUTION DeNovo ...

Home March 14, 2023
Home
News | Cardiovascular Clinical Studies

March 13, 2023 — BioCardia, Inc., developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2023
Home
News | Pediatric Cardiology

March 13, 2023 — An enlarged heart, often described as left ventricular hypertrophy, is a sign of early cardiac damage ...

Home March 13, 2023
Home
News | ECG

March 13, 2023 — iRhythm Technologies, Inc., a leading digital health company focused on creating trusted solutions that ...

Home March 13, 2023
Home
News | ACC

March 12, 2023 — As part of its ongoing news coverage of ACC23, the DAIC/dicardiology.com editorial team has condensed ...

Home March 12, 2023
Home
News | ESC

March 10, 2023 — The first evidence that exceeding the World Health Organization (WHO) ozone limit is associated with ...

Home March 11, 2023
Home
News | Coronavirus (COVID-19)

March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute ...

Home March 10, 2023
Home
News | Pulmonary Embolism

March 10, 2023 — Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of ...

Home March 10, 2023
Home
News | Atrial Fibrillation

March 9, 2023 — People with a recent diagnosis of atrial fibrillation (AF), the most common irregular heart rhythm, have ...

Home March 09, 2023
Home
News | Pediatric Cardiology

March 9, 2023 — An enlarged heart, often described as left ventricular hypertrophy, is a sign of early cardiac damage ...

Home March 09, 2023
Home
News | ACC

March 9, 2023 — C. Noel Bairey Merz, MD, FACC, professor of cardiology and the director of the Barbra Streisand Women’s ...

Home March 09, 2023
Home
News | ACC

March 9, 2023 — Positive results from a Mineralys Therapeutics study, the Target-HTN Phase 2 trial, demonstrated ...

Home March 09, 2023
Home
News | Peripheral Artery Disease (PAD)

March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...

Home March 08, 2023
Home
News | Atrial Fibrillation

March 8, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 08, 2023
Home
Subscribe Now